Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency

Am J Cardiol. 1999 Jan 15;83(2):260-3, A5. doi: 10.1016/s0002-9149(98)00833-9.

Abstract

In phase 1 of this study, 60 patients undergoing coronary angioplasty were randomized to receive saline, dopamine, or aminophylline; the overall incidence of contrast-induced renal failure was 38%, without difference among the 3 groups. In phase 2 of this study, 72 patients with established contrast-induced renal failure were randomized to receive saline or dopamine; dopamine had a deleterious effect on the severity of renal failure, prolonging the course.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Acute Kidney Injury / prevention & control*
  • Aged
  • Aminophylline / therapeutic use*
  • Angioplasty, Balloon, Coronary
  • Cardiotonic Agents / adverse effects
  • Cardiotonic Agents / therapeutic use*
  • Contrast Media / adverse effects*
  • Creatinine / blood
  • Dopamine / adverse effects
  • Dopamine / therapeutic use*
  • Female
  • Humans
  • Male
  • Renal Insufficiency / complications*
  • Sodium Chloride / therapeutic use

Substances

  • Cardiotonic Agents
  • Contrast Media
  • Aminophylline
  • Sodium Chloride
  • Creatinine
  • Dopamine